MERS-CoV spike protein: a key target for antivirals

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/14728222.2017.1271415PMID 27936982PMCID PMC5457961
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection

  2016cited by this paper
• MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

  2016cited by this paper
• Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection

  2016cited by this paper
• Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir

  2016cited by this paper
• Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)

  2016cited by this paper
• Institutional Preparedness to Prevent Future Middle East Respiratory Syndrome Coronavirus-Like Outbreaks in Republic of Korea

  2016cited by this paper
• 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012

  2016cited by this paper
• Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection

  2016cited by this paper
• Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

  2016cited by this paper
• Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection

  2015cited by this paper
• Evaluation of candidate vaccine approaches for MERS-CoV

  2015cited by this paper
• Lessons to learn from MERS-CoV outbreak in South Korea.

  2015cited by this paper
• An Outbreak of Middle East Respiratory Syndrome Coronavirus Infection in South Korea, 2015

  2015cited by this paper
• Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond

  2015cited by this paper
• Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS‐CoV)

  2015cited by this paper
• Middle East respiratory syndrome

  2015cited by this paper
• Be vigilant: New MERS-CoV outbreaks can occur in the Kingdom of Saudi Arabia

  2015cited by this paper
• Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

  2015cited by this paper
• Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels

  2015cited by this paper
• Emerging Diseases

  2015cited by this paper
• A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein

  2015cited by this paper
• A48 Inference of biological functionality in individual genomic secondary structural elements found within capulavirus genomes

  2015cited by this paper
• Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus

  2015cited by this paper
• Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

  2015cited by this paper
• Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015

  2015cited by this paper
• Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS)

  2015cited by this paper
• Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea

  2015cited by this paper
• MERS – A cautionary tale

  2015cited by this paper
• 2015 MERS outbreak in Korea: hospital-to-hospital transmission

  2015cited by this paper
• Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease

  2015cited by this paper
• Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody

  2015cited by this paper
• Intranasally administered peptidic viral fusion inhibitor protected hDPP4 transgenic mice from MERS-CoV infection

  2015cited by this paper
• Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control

  2015cited by this paper
• Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27

  2015cited by this paper
• Emerging Problems in Infectious Diseases Lessons to learn from MERS-CoV outbreak in South Korea

  2015cited by this paper
• MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia

  2014cited by this paper
• Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity

  2014cited by this paper
• Current advancements and potential strategies in the development of MERS-CoV vaccines

  2014cited by this paper
• A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein

  2014cited by this paper
• Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies

  2014cited by this paper
• Estimation of MERS-Coronavirus Reproductive Number and Case Fatality Rate for the Spring 2014 Saudi Arabia Outbreak: Insights from Publicly Available Data

  2014cited by this paper
• IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms

  2014cited by this paper
• Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

  2014cited by this paper
• Geographic Distribution of MERS Coronavirus among Dromedary Camels, Africa

  2014cited by this paper
• Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

  2014cited by this paper
• Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.

  2014cited by this paper
• Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

  2014cited by this paper
• Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels

  2014cited by this paper
• Evidence for camel-to-human transmission of MERS coronavirus.

  2014cited by this paper
• Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies

  2014cited by this paper
• Rapid generation of a mouse model for Middle East respiratory syndrome

  2014cited by this paper
• Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26

  2014cited by this paper
• Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013

  2014cited by this paper
• Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection

  2014cited by this paper
• Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4

  2014cited by this paper
• Evidence for camel-to-human transmission of MERS coronavirus.

  2014cited by this paper
• Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein

  2014cited by this paper
• MERS Coronavirus in Dromedary Camel Herd

  2014cited by this paper
• Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

  2014cited by this paper
• An Observational, Laboratory-Based Study of Outbreaks of Middle East Respiratory Syndrome Coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014

  2014cited by this paper
• Emerging diseases. Soaring MERS cases in Saudi Arabia raise alarms.

  2014cited by this paper
• Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein

  2014cited by this paper
• MERS Coronaviruses in Dromedary Camels, Egypt

  2014cited by this paper
• Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

  2013cited by this paper
• Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

  2013cited by this paper
• The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

  2013cited by this paper
• Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus

  2013cited by this paper
• Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

  2013cited by this paper
• Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus

  2013cited by this paper
• Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

  2013cited by this paper
• Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

  2013cited by this paper
• Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus

  2013cited by this paper
• Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody

  2013cited by this paper
• Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat, South Africa

  2013cited by this paper
• Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat

  2013cited by this paper
• Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2

  2013cited by this paper
• Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation

  2013cited by this paper
• Evolution and emergence of therapeutic monoclonal antibodies: what cardiologists need to know.

  2013cited by this paper
• Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

  2013cited by this paper
• Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate

  2013cited by this paper
• Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia

  2013cited by this paper
• Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

  2013cited by this paper
• Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans

  2012cited by this paper
• Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

  2012cited by this paper
• Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

  2012cited by this paper
• Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus.

  2012cited by this paper
• Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5

  2012cited by this paper
• Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

  2012cited by this paper
• Strategies and challenges for the next generation of therapeutic antibodies

  2010cited by this paper
• The safety and side effects of monoclonal antibodies

  2010cited by this paper
• The spike protein of SARS-CoV — a target for vaccine and therapeutic development

  2009cited by this paper
• Therapeutic antibodies: successes, limitations and hopes for the future

  2009cited by this paper
• Comparative Analysis of Twelve Genomes of Three Novel Group 2c and Group 2d Coronaviruses Reveals Unique Group and Subgroup Features

  2006cited by this paper
• Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions

  2006cited by this paper
• Core structure of S2 from the human coronavirus NL63 spike glycoprotein.

  2006cited by this paper
• Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

  2005cited by this paper
• Crystal Structure of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Fusion Core*

  2004cited by this paper
• Structural Basis for Coronavirus-mediated Membrane Fusion

  2004cited by this paper
• Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

  2004cited by this paper
• Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

  2004cited by this paper

• AI-Guided Binding Mechanisms and Molecular Dynamics for MERS-CoV.

  2026cites this paper
• Evolutionary Insight into Fatal Human Coronaviruses (hCoVs) with a Focus on Circulating SARS-CoV-2 Variants Under Monitoring (VUMs)

  2025cites this paper
• A novel neutralizing antibody recognizing a conserved conformational epitope in PDCoV S1 protein and its therapeutic efficacy in piglets

  2025influential citation
• A Narrative Review on the Recent Insights Into the Pathogenicity and Potential Role of Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) in the Emergence of “Disease X”

  2025cites this paper
• Developments in treatment for middle east respiratory syndrome coronavirus (MERS-CoV)

  2024cites this paper
• The glycosylation sites in RBD of spike protein attenuate the immunogenicity of PEDV AH2012/12

  2024cites this paper
• An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

  2024cites this paper
• A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus

  2024cites this paper
• Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

  2024cites this paper
• Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach

  2024cites this paper
• Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen

  2024influential citation
• Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor

  2024cites this paper
• Cross-sectional evaluation of anti-SARS-CoV-2 antibody response to AZD1222 recombinant vaccine deployment in the Bono Region, Ghana.

  2024cites this paper
• Functional Activity and Binding Specificity of small Ankyrin Repeat Proteins called Ankyrons against SARS-CoV-2 variants

  2024cites this paper
• Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV

  2024cites this paper
• Human Coronavirus Cell Receptors Provide Challenging Therapeutic Targets

  2023influential citation
• Highly Selective Aptamer‐Molecularly Imprinted Polymer Hybrids for Recognition of SARS‐CoV‐2 Spike Protein Variants

  2023cites this paper
• Paradigm of Well-Orchestrated Pharmacokinetic Properties of Curcuminoids Relative to Conventional Drugs for the Inactivation of SARS-CoV-2 Receptors: An In Silico Approach

  2023cites this paper
• Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies

  2023cites this paper
• An overview of the recent progress in Middle East Respiratory Syndrome Coronavirus (MERS-CoV) drug discovery

  2023cites this paper
• Journal Pre-proof Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2

  2023cites this paper
• Modulating SARS-CoV-2 Spike Protein Reactivity through Moderate Electric Fields: A Pathway to Innovative Therapies

  2023cites this paper
• MICaFVi: A Novel Magnetic Immuno-Capture Flow Virometry Nano-Based Diagnostic Tool for Detection of Coronaviruses

  2023cites this paper
• Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization

  2023cites this paper
• Molecular Basis of the Structure and Transmission of SARS-CoV, SARS-CoV-2, and MERS: A Review Report

  2023cites this paper
• Journal Pre-proof Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2

  2023cites this paper
• SARS-Cov-2 Spike-S1 Antigen Test Strip with High Sensitivity Endowed by High-Affinity Antibodies and Brightly Fluorescent QDs/Silica Nanospheres

  2023cites this paper
• Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19

  2023cites this paper
• Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases

  2023cites this paper
• CompCorona: A Web Portal for Comparative Analysis of the Host Transcriptome of PBMC and Lung SARS-CoV-2, SARS-CoV, and MERS-CoV

  2023cites this paper
• MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection

  2023cites this paper
• Innovation-driven trend shaping COVID-19 vaccine development in China

  2023cites this paper
• A Multifaceted Computational Approach to Understanding the MERS-CoV Main Protease and Brown Algae Compounds’ Interaction

  2023cites this paper
• Design of MERS-CoV Entry Inhibitory Short Peptides Based on Helix-stabilizing Strategies.

  2023cites this paper
• Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2

  2023cites this paper
• Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein.

  2023cites this paper
• Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice

  2022cites this paper
• In Vitro Screening and MD Simulations of Thiourea Derivatives against SARS-CoV-2 in Association with Multidrug Resistance ABCB1 Transporter

  2022cites this paper
• Pan‐coronavirus fusion inhibitors to combat COVID‐19 and other emerging coronavirus infectious diseases

  2022cites this paper
• Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development

  2022cites this paper
• Two Years into the COVID-19 Pandemic: Lessons Learned

  2022cites this paper
• Exploring whole proteome to contrive multi-epitope-based vaccine for NeoCoV: An immunoinformtics and in-silico approach

  2022influential citation
• DiMA: sequence diversity dynamics analyser for viruses

  2022cites this paper
• Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus: In Silico Study Immunomodulatory Drugs.

  2022cites this paper
• Effect of herbal compounds on coronavirus; a systematic review and meta-analysis

  2022cites this paper
• Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples

  2022cites this paper
• Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies.

  2022cites this paper
• Liposome-Mediated Delivery of MERS Antigen Induces Potent Humoral and Cell-Mediated Immune Response in Mice

  2022cites this paper
• The free fatty acid–binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron

  2022cites this paper
• Evaluation of anti-SARS-CoV-2 antibody response to COVID-19 vaccine deployment in the Bono Region, Ghana.

  2022cites this paper
• Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy

  2022cites this paper
• In silico study of substrate chemistry effect on the tethering of engineered antibodies for SARS-CoV-2 detection: Amorphous silica vs gold

  2022cites this paper
• Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections

  2022cites this paper
• Structural Analysis of the Spike Protein of SARS-CoV-2 Variants and Other Betacoronaviruses Using Molecular Dynamics.

  2022cites this paper
• Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding

  2022cites this paper
• Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2

  2022cites this paper
• Role of Imaging in the COVID-19 Pandemic

  2022cites this paper
• Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition

  2022cites this paper
• SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants

  2022cites this paper
• The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management

  2021cites this paper
• An overview of vaccine development for COVID-19

  2021cites this paper
• COVID-19 Infection in the Human Reproductive Tract of Men and Nonpregnant Women

  2021cites this paper
• Does CT help in reducing RT-PCR false negative rate for COVID-19?

  2021cites this paper
• Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study

  2021cites this paper
• High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa

  2021cites this paper
• Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic

  2021cites this paper
• Development of Coronavirus Treatments Using Neutralizing Antibodies

  2021cites this paper
• Nanomaterials-Based Sensors for Respiratory Viral Detection: A Review

  2021cites this paper
• Peptide enzyme‐linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine

  2021cites this paper
• Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19

  2021cites this paper
• The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options

  2021cites this paper
• Active site‐based analysis of structural proteins for drug targets in different human Coronaviruses

  2021cites this paper
• Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies

  2021cites this paper
• Identification of a Novel Neutralizing Epitope on the N-Terminal Domain of the Human Coronavirus 229E Spike Protein

  2021cites this paper
• TMPRSS2 As an Influential Human Gene for COVID-19

  2021cites this paper
• Angiotensin Converting Enzyme 2 (ACE2) Expression in the Aged Brain and Visual System

  2021cites this paper
• ACE-2; an Entry Receptor for SARS-CoV-2

  2021cites this paper
• Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants

  2021cites this paper
• An Insight Into Detection Pathways/Biosensors of Highly Infectious Coronaviruses

  2021cites this paper
• Computational Chemistry to Repurposing Drugs for the Control of COVID-19

  2021cites this paper
• An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks

  2021cites this paper
• Immunological Approaches to the Treatment of New Coronavirus Infection (Review)

  2021cites this paper
• Immune Responses to MERS-CoV in Humans and Animals.

  2021cites this paper
• SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines

  2021cites this paper
• In silico antibody engineering for SARS-CoV-2 detection

  2021cites this paper
• Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor

  2021cites this paper
• A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses

  2021cites this paper
• Neurological pathophysiology of SARS‐CoV‐2 and pandemic potential RNA viruses: a comparative analysis

  2021cites this paper
• Advances in mRNA and other vaccines against MERS-CoV

  2021cites this paper
• Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines

  2021cites this paper
• Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

  2021cites this paper
• The variants of SARS‐CoV‐2 and the challenges of vaccines

  2021cites this paper
• Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19

  2021cites this paper
• Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods

  2021cites this paper
• Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD

  2021cites this paper
• SARS-CoV-2: vaccines in the pandemic era

  2021cites this paper
• Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung

  2021cites this paper
• Therapeutically effective covalent spike protein inhibitors in treatment of SARS-CoV-2

  2021cites this paper
• Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies

  2021cites this paper
• Novel Coronavirus Disease (COVID-19): An extensive study on evolution, global health, drug targets and vaccines

  2021cites this paper